Clinical trial B9991033
A phase 1b/2 study to evaluate safety and clinical activity of Avelumab in combination with Binimetinib with or without Talazoparib in patients with locally advanced or metastatic ras-mutant solid tumors
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/2 |
Academic trial | Non |
Sponsor | Pfizer |
EudraCT Identifier | 2018-000124-34 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03637491 |
Inclusion criteria | KRAS/RAS mutation |
Last update |